APA (7th ed.) Citation

Ohba, S., Teranishi, T., Matsumura, K., Kumon, M., Kojima, D., Fujiwara, E., . . . Hirose, Y. (2025). Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-85339-x

Chicago Style (17th ed.) Citation

Ohba, Shigeo, et al. "Factors Involved in Maintaining Karnofsky Performance Status (≥ 50%) in Glioblastoma, IDH-wildtype Patients Treated with Temozolomide and Radiotherapy." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-85339-x.

MLA (9th ed.) Citation

Ohba, Shigeo, et al. "Factors Involved in Maintaining Karnofsky Performance Status (≥ 50%) in Glioblastoma, IDH-wildtype Patients Treated with Temozolomide and Radiotherapy." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-85339-x.